|
Real-time Estimate
Cboe BZX
19:20:43 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.475 USD | -0.67% |
|
-1.01% | +28.26% |
| Market Cap | 661M 593M 548M 496M 927M 62.93B 939M 6.55B 2.61B 32.93B 2.48B 2.43B 105B | P/E 2026 * |
-8.74x | P/E 2027 * | -7.43x |
|---|---|---|---|---|---|
| Enterprise Value | 661M 593M 548M 496M 927M 62.93B 939M 6.55B 2.61B 32.93B 2.48B 2.43B 105B | EV / Sales 2026 * |
17.8x | EV / Sales 2027 * | 39x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LXRX | Delayed | |
CBOE
| LXRX | Real-time | |
|
Tradegate
| LX31 | Real-time |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 day | -0.67% | ||
| 1 week | -1.01% | ||
| Current month | -21.33% | ||
| 1 month | -21.54% | ||
| 3 months | -36.42% | ||
| 6 months | -4.84% | ||
| Current year | +28.26% |
| 1 week | 1.36 |  | 1.52 |
| 1 month | 1.36 | | 1.95 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1.1 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 5.79 |
| 10 years | 0.28 | | 18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 08/07/2024 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 02/01/2025 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 01/01/2005 |
Ray Debbane
CHM | Chairman | 71 | 27/02/2012 |
| Director/Board Member | 67 | 28/08/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/06/26 | Exercice | Director | 178,624 | 0.0402% | ||
| 03/06/26 | Exercice | Director | 178,624 | 0.0402% | ||
| 03/06/26 | Exercice | Director | 178,624 | 0.0402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.67% | -1.01% | +10.90% | +22.92% | 661M | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +1.08% | +2.86% | +12.45% | +84.22% | 55.53B | |
| +1.41% | +1.50% | +12.73% | +104.69% | 53.03B | |
| -0.47% | -0.56% | +27.05% | +56.21% | 45.99B | |
| +0.16% | -2.48% | +18.40% | +99.76% | 42.45B | |
| +1.24% | +1.13% | +227.15% | +934.39% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -0.94% | +43.90% | +105.43% | +91.81% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | -0.08% | +2.96% | +48.50% | +149.46% | 39.32B | |
| Weighted average by Cap. | +0.22% | +3.12% | +49.64% | +160.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.17M 33.35M 30.83M 27.93M 52.17M 3.54B 52.8M 369M 147M 1.85B 139M 137M 5.88B | 16.93M 15.19M 14.04M 12.72M 23.76M 1.61B 24.05M 168M 66.87M 844M 63.52M 62.18M 2.68B |
| Net income | -73.77M -66.18M -61.19M -55.42M -104M -7.03B -105M -732M -291M -3.68B -277M -271M -11.67B | -97.05M -87.07M -80.5M -72.91M -136M -9.24B -138M -963M -383M -4.84B -364M -357M -15.35B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | $1.480 | -0.34% | 374,860 |
| 28/10/26 | $1.485 | +0.34% | 1,618,937 |
| 27/10/26 | $1.480 | +2.07% | 1,861,649 |
| 26/10/26 | $1.450 | +2.11% | 2,205,901 |
| 23/10/26 | $1.420 | -4.70% | 2,684,899 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
